Introduction 1
The role of commensal bacteria in health and disease is receiving increasing interest with the 2 recognition that the microbiota plays a central role in shaping immune function, metabolism and protection 3 from pathogenic microorganisms (1-3). The human lung has historically been considered sterile due to the 4 absence of cultivable bacteria in bronchial alveolar lavage fluids from healthy individuals (4-6). However, 5 culture-independent molecular methods for bacterial identification have recently been applied to 6 characterize the human airway microbiota (7-11). Gram-negative anaerobic Prevotella species were found 7 to be a prevalent bacterial colonizer of healthy airways (7, 11), and reduced frequencies were reported in 8 chronic obstructive pulmonary disease (COPD) and asthma (7) . Prevotella species are considered 9 commensal bacteria that rarely cause respiratory infections, and only few strains have been reported to be 10 opportunistic in chronic infections, abscesses and anaerobic pneumonia (12) (13) (14) . 11
Dysbiosis, a change in microbiota composition detrimental for host health, is associated with altered 12 function of the immune system and inflammatory pathologies (15). It is becoming increasingly appreciated 13 that respiratory bacterial pathogens commonly colonize the lower airways of patients with COPD and 14 asthma (7, 16, 17) . Both stable disease and exacerbation episodes in COPD are predominantly associated 15 with the presence of pathogenic Gram-negative Proteobacteria (Haemophilus influenzae and Moraxella 16 catarrhalis) (18) (19) (20) . The pathogenic Proteobacteria are believed to take part in disease progression of 17 COPD by enhancing inflammatory processes and tissue degradation in the lower airways (21). Indeed, 18 higher bacterial loads in the airways are associated with increased disease severity, exacerbation 19 frequency, decreased lung function and increased production of inflammatory mediators (22) (23) (24) . The 20 notion of disease-promoting properties of bacteria is further supported by a recent interventional study 21
showing that prophylactic antibiotic treatment reduced the frequency of bacterial colonization and 22 exacerbations in COPD (25). 23
A role for pathogenic Proteobacteria in asthma pathology remains controversial and few studies are 24 found in the literature. Increased airway colonization by pathogenic Proteobacteria is associated with 25 stable asthma in children and adults (7), exacerbation episodes in childhood (26) and increased risk of 1 developing asthma (17) . We recently reported abnormal bacterial immune responses in infants later 2 developing asthma proposing that asthmatics exhibit decreased bacterial control and that divergent 3 bacterial immune responses within the lung may contribute to asthma pathology in some disease 4 endotypes (27). 5
Studies using murine models of COPD demonstrated that Haemophilus influenzae enhances airway 6 inflammation induced by cigarette smoke exposure (28, 29). Furthermore, mice challenged in the airways 7
with Haemophilus influenzae lysates develop inflammatory features of COPD, including production of pro-8 inflammatory mediators TNFα, IL-6 and IL-1β, airway neutrophilia and lung tissue pathology (30). 9
Commensal Prevotella species are frequent colonizers of the lower and upper airways; however little 10 is known about the inflammatory properties of these bacterial species in the respiratory system. Since 11 pathogenic Proteobacteria are recognized co-drivers of chronic airway inflammation in COPD and have 12 been studied in relevant murine models of the disease, we here compared these to the commensal 13
Prevotella spp. We demonstrate weak innate stimulatory properties of Gram-negative commensal 14
Prevotella spp. that may make colonization by these bacteria tolerable by the respiratory immune system. 15
On the contrary, the innate stimulatory capacity of pathogenic Proteobacteria likely allow these bacteria to 16 be specific co-drivers of disease progression in COPD and asthma patients. 17 conditions. Prevotella strains were grown on anaerobic agar plates (Statens Serum Institut) under 30°C 17 anaerobic conditions. All strains were resuspended from plates with uniform growth and washed once in 18 PBS. Bacteria were resuspended in PBS to OD 1 and UV-irradiated for 45 minutes. UV killing were confirmed 19 by plating. Dry weight of bacterial suspensions in PBS was determined on 3x1 ml portions after freeze-20 drying (subtracted by weight of PBS). Bacterial suspensions were frozen and stored at -80°C. 
18

Materials and Methods
Primary lung cell preparation and stimulation 2
Mice were anesthetized using Ketamine/Xylazine (10/0.5 mg pr. 50 g body weight; Intervet, 3 Boxmeer, Holland) and euthanized by heart puncture blood removal. PBS was perfused through the heart 4 to remove systemic blood. Lungs were excised, cut into 1-2 mm pieces and incubated for 1h at 37°C in PBS 5 (Lonza, Basel, Switzerland) supplemented with 30U/ml Clostridium histolyticum collagenase type II and 150 6 ug/ml DNAase (Sigma-Aldrich, Copenhagen, Denmark). The tissues were passed through a 70 µm cell 7 strainer (BD Bioscience) to obtain a single cell suspension of lung cells. Cells from lungs of 3-5 mice were 8 pooled and separated into lung constituent cells (CD45-) and lung leukocytes (CD45+) using a CD45+ 9 magnetic cell sorting kit (MACS; MiltenyiBiotec, Bergisch Gladbach, Germany) according to manufacturer's 10 recommendations. Purity was confirmed by flow cytometry. Cells were resuspended in complete RPMI 11 1640 medium (Lonza, Basel, Switzerland; supplemented with 2 mM L-glutamine (Cambrex, East Rutherford, 12 NJ), 100 U/ml penicillin/streptomycin (Lonza) and 10 % FCS (Lonza)) and plated in 96-well plates (2*10 5 13 cells/well). In experiments with mixed CD45-and CD45+ lung cells a ratio of 1:1 was used. 14 Primary lung cells were stimulated with 50 µg/ml of bacterial preparations supplemented with 50 15 µg/ml gentamycin (Sigma-Aldrich) to ensure no bacterial outgrowth. LPS (100 ng/ml) and medium alone 16 were included to serve as a positive and negative control, respectively. All stimulations were done in 17 triplicates. Supernatants were harvested after 24 hours and stored at -80°C until cytokine analyses. 18
19 Acute airway inflammation model 20
Mice were lightly sedated using Ketamine/Xylazine (5 mg/0.25 mg pr. 50 g body weight). While kept 21 in a vertical position, 25 µl bacterial suspension or vehicle (PBS) alone was inhaled through each nostril 22 giving a final dose of 22.5 µg bacteria in 50 µl (450 µg/ml). Mice were kept vertical for 1 minute following 23 inhalation. 24 24 hours after bacterial inhalation, the mice were anesthetized using Ketamine/Xylazine (10 mg/0.5 1 mg pr. 50g body weight) and euthanized by heart puncture. Bronchoalveolar lavage (BAL) cells were 2 collected by prefusing lungs with 800 µl PBS five times. Right lung was snap frozen in liquid nitrogen and 3 stored at -80⁰C until measurement of tissue cytokines. Left lung was embedded in Tissue-tek OCT 4
Compound (Sakura, Tokyo, Japan) and stored at -80°C until histochemical analysis. 5 6
Tissue and supernatant cytokine measurements 7
Measurement of cytokine production in tissue was performed as previously described.(31) Frozen 8 lung tissue were homogenized in a mortar with 500 ul/mg tissue PBS contain 0.1% Tween-20 (v/v) and 9 protease inhibitor cocktail (Complete, Roche, 1 tablet/50 ml PBS). Tissue homogenates were frozen in liquid 10 nitrogen, thawed, sonicated for 30s and centrifuged to remove debris. Lysates were stored at -80°C until 11 cytokine analysis by ELISA. 12 Cytokines were measured in lung tissue homogenates and supernatants from cell cultures using 13 commercial ELISA kits (IL-5, IL-4 and IL-13 from eBioscience, San Diego, CA; MIP-2α (IL-8), TSLP, TNFα, IL-10, 14
IFNγ, IL-17, CCL20, CXCL16, IL-1β, IL-6 and IL-10 from RnD Systems, Minneapolis, MN) according to 15 manufacturer's recommendations. 16 17
Flow cytometry 18
The composition of BAL cells was analyzed by flow cytometry as previously described (32) Bioscience) for 30 minutes at 4°C. Cells were analyzed on a BD FACSCanto™ II system running FACSdiva 6.0 23 software (BD Biosciences, San Jose, CA). Immune cells were identified among CD45+ leukocytes as follows: 24 Eosinophils (CD11c-, Siglec-F+), lymphocytes (CD11b-CD11c-), macrophages (F4/80+Gr-1-), neutrophils 25 (F4/80-Gr-1+), monocytes (F4/80-Gr-1-CD11bintCD11c-), CD11b+ dendritic cells (CD11b+ DCs; F4/80-Gr-1-1 CD11b+CD11c+) and CD11b-/low dendritic cells (CD11b-/low DCs; F4/80-Gr-1-CD11bintCD11c+). Flow 2 cytometry data was analyzed using FlowJo 7.6.5 (Tree Star, Ashland, OR). Haemophilus influenzae (H. inf. NT) strains, as these common strains are structurally different due to the 9 presence or absence of bacterial capsule, respectively (33, 34). Prevotella melaninogenica (P. mel.), 10
Prevotella nanceiensis (P. nan.) and Prevotella salivae (P. sal.) were included as representative commensal 11
Prevotella spp predominantly associated with healthy airways (7, 11). The innate inflammatory capacities of 12 the Proteobacteria and Prevotella spp were addressed by stimulating primary CD45+ and CD45-cells 13 isolated from murine lungs representing lung leukocytes and non-immune cells, respectively. The 14 production of key acute-phase cytokines MIP-2α (IL-8) and TNFα known to be involved in COPD and asthma 15 pathology were analyzed in supernatants (35). IL-10 was analyzed to address potential anti-inflammatory 16 aspects of the bacterial response. TSLP production was addressed as a cytokine produced exclusively by 17 epithelial cells, and involved in priming of type-2 immune responses (36) . In addition, cytokines IL-5, IL-4 18 and IL-13 were analyzed to assess potential type-2 immune responses induced by the bacteria. Co-cultures 19 of CD45+ and CD45-cells (1:1) were performed to examine possible cytokine-enhancing cross talk between 20 these cellular compartments. 21
We observed significant differences between the cytokine profiles induced in primary murine lung 22 cells by the COPD and asthma-associated Proteobacteria and the commensal Prevotella spp ( figure 1A) . 23
Prevotella spp generally induced lower cytokine production compared to Proteobacteria, but the 24 observation was dependent on the cytokine investigated and the cellular compartment. In CD45+ lung cells, 25
Prevotella spp induced lower TNFα production compared to the three Proteobacteria. Additionally, TNFα, 1 MIP-2α (IL-8) and TSLP were lower for Prevotella spp in the CD45-compartment. These cytokines and IL-10 2 were also produced less in response to Pretovella spp in 1:1 co-cultures of CD45+ and CD45-cells isolated 3 from murine lungs ( figure 1A) . Interestingly, measurements of MIP-2α (IL-8) production indicated a 4 synergistic effect between CD45+ and CD45-cells giving rise to generally higher MIP-2α (IL-8) levels in co-5 cultures. It is observed that production of some cytokines is restricted to a particular compartment. 6
Expectedly, TSLP was only produced in CD45-lung cells, as this is an epithelial-derived cytokine (36) . IL-5 7 production was absent in the CD45-compartment indicating this cytokine is only produced by lung immune 8 cells. Furthermore, MIP-2α (IL-8), TNFα and IL-10 were generally lower in the non-immune CD45-lung cell 9 compartment. IL-4 and IL-13 production in response to the bacteria could not be detected in bacteria-10 exposed CD45+ or CD45-lung cells (data not shown). 11
The observed differences in innate immune stimulatory properties between the three COPD and 12 asthma-associated Proteobacteria and the commensal Prevotella spp could be due to differences in 13 concentrations of specific innate ligands (microbe-associated molecular patterns, MAMPs) shared by the 14 bacteria. To test this, we stimulated primary lung cells isolated from mice with increasing concentrations of 15 the three Proteobacteria and Prevotella spp. TNFα and TSLP were measured as representative cytokines 16 with observed differences in production induced by the two groups of bacteria in the CD45+ and CD45-17 lung cells compartments, respectively. The cytokine response to increasing concentrations of bacteria from 18 the Proteobacteria and Prevotella spp fitted well to a one-site saturation binding equation ( figure 1B) . 19
There was a significant difference in the maximum capacity of the Proteobacteria and Prevotella spp to 20 induce innate stimulation in lung cells (TNFα from CD45+ lung cells, Bmax 1378 pg/ml vs. 1021 pg/ml, p < 21 0.0001; TLSP from CD45-lung cells, Bmax 53.2 pg/ml vs. 30.5 pg/ml, p < 0.0001). These findings 22 demonstrate intrinsic innate stimulatory divergence between the three COPD and asthma-associated 23
Proteobacteria and commensal Prevotella spp likely due to differences in composition of microbial-24 associated molecular patterns (MAMPs) with alternating capacity to activate innate immune receptors. 25 1
COPD and asthma-associated non-typeable Haemophilus influenzae, but not Prevotella nanceiensis, 2 potently induce airway inflammation and pathology in mice 3
Airway challenge with Haemophilus influenzae has been shown to induce inflammatory aspects of 4 COPD in lungs of mice, including production of acute phase cytokines TNFα, IL-6 and IL-1β, airway 5 neutrophilia and tissue pathology (30). We sought to investigate how the intrinsic differences in immune 6 stimulatory capacity between the three Proteobacteria and Prevotella spp may translate to the 7 presentation of COPD-and/or asthma-like airway inflammation in vivo. We challenged mice with 8 figure 2D and 2E) . These findings suggest that Prevotella spp 5 associated with healthy lungs may be intrinsically tolerated by the respiratory immune system, whereas 6 pathogenic Proteobacteria exhibit distinct properties that can mediate COPD-like inflammatory features. 7 8
A different role for TLR2 in airway inflammation mediated by non-typeable Haemophilus Influenzae and 9
Prevotella nanceiensis 10
Toll-like receptors (TLRs) play an important role in mediating inflammation by recognizing conserved 11
MAMPs. TLR4 is the receptor for LPS, a molecule classical viewed as the most potent MAMP found in Gram-12 negative bacteria. Activation of TLR4 and TLR2 has been reported to account for up to 90 % of the 13 inflammatory response to common pathogenic Gram-negative bacteria (39). Both the Proteobateria and 14
Prevotella spp analyzed in this study are Gram-negative and contain LPS with the potential to activate TLR4. 15 However, the two groups of bacteria may have different TLR4 activating properties. This is exemplified by, 16 the gut commensal Gram-negative Bacteroides fragilis of the same phylum as the Prevotella spp 17 (Bacteroidetes), which have been shown to activate TLR2, but not TLR4 (40). It is possible to address the 18 contribution of TLR2 in TLR2 KO mice, and hence indirectly examine the contribution from other ligands, 19 such as LPS (TLR4). The role of TLR2 in the airway inflammatory response to Haemophilus influenzae (H. inf. 20 NT) and Prevotella nanceiensis (P. nan.) was compared using WT and TLR2-/-mice. We found TLR2 to be 21 dispensable for acute airway neutrophilia and lung tissue pathology mediated by H. inf. NT ( figure 3A and  22   3C ). However, MIP-2α (IL-8) production in the lung in response to H. inf. NT was diminished in TLR2-23 deficient mice ( figure 3B) , indicating that MIP-2α (IL-8) is not essential for full expression of airway 24 neutrophilia. 25 Airway inflammation mediated by P. nan. was found to be completely dependent on TLR2. Cellular 1 recruitment in airways was absent (no difference when compared to PBS-treated group) and none of the 2 analyzed cytokines were found to be induced (tested by Student's one-sample t-test) in response to P. nan. 3 in TLR2-deficient mice ( figure 3A and 3B) . Expectedly, also TLR2-deficient mice showed no lung pathology in 4 response to P. nan. ( figure 3C) . These findings indicate that the innate stimulatory potential of Prevotella 5 spp is mainly related to TLR2 activation, whereas pathogenic Proteobacteria stimulate via other immune 6 receptors that can fully express COPD-like inflammatory features. shown that TLR4 and TLR2 account for approximate 90 % of the pro-inflammatory innate response of 8 human leucocytes to common pathogenic Gram-negative bacteria (39). Here we found that airway 9 inflammation driven by Prevotella spp was completely dependent on TLR2. This finding suggests that 10
Prevotella spp do not contain immunostimulatory LPS that can mediate airway inflammation. Indeed, the 11 difference in inflammatory potential between the Gram-negative COPD and asthma-associated 12
Proteobacteria and commensal Prevotella spp can likely be ascribed to differences in LPS structures (41). It 13 is known that tetra-and penta-acylated LPS structures retain lower stimulatory activity on TLR4 than hepta-14 and hexa-acylated LPS (42, 43). The prototypic hexa-acylated LPS of E. coli seems to be the most biologically 15 potent structure, whereas LPS with fewer and shorter acyl-chains have lower capacity to stimulate TLR4 16 (44) (45) (46) . Haemophilus influenzae and Moraxella catarrhalis has been reported to contain hexa-and hepta-17 acylated LPS, respectively (47, 48). On the contrary, Prevotella spp and other members of the Bacteroidetes 18 phylum have been reported to contain penta-acylated LPS, which have implications for recognition of the 19 bacteria by TLR4. LPS isolated from the oral commensal Prevotella intermedia demonstrate approximate 20 10-fold reduced potency to induce IL-6 in murine macrophages as compared to E. coli LPS (49). 21 Furthermore, the gut commensal Bacteroides fragilis contain penta-acylated LPS (50), and this bacterium 22 has been found to stimulate TLR2 but not TLR4 (40). The presence of immune inactive LPS in all Prevotella 23 spp is supported by a recent bioinformatic-based analysis performed by our group. We analyzed all 24 sequenced bacterial genomes publicly available and studied the genes involved in LPS synthesis. We found 25 that the LpxM gene encoding the enzyme (KDO)2-(lauroyl)-lipid IVA acyltransferase needed to add a 6 th acyl 1 chain to lipid A (important for TLR4 immune activity) is absent in all members of the Bacteroidetes phylum 2
including Prevotella spp, but present in gamma-Proteobacteria such as H. influenzae (Brix et al., manuscript 3 in revision). 4
In the present report, Prevotella spp associated with healthy human lungs was well-tolerated in 5 murine airways by inducing limited neutrophilia, chemokine and cytokine production, as well as provoking 6 no detectable lung immunopathology as compared to pathogenic Proteobacteria. Observational studies 7 reporting lung dysbiosis with increased pathogenic proteobacteria and reduced Prevotella spp. in COPD and 8 asthma (7) suggest that the well-tolerated Prevotella spp serves a disease-protective role. A protective role 9
of Prevotella spp. could be ascribed to 1) a direct modulation of innate immune responses in the lung, 2) 10 induction of functional and developmental changes in the immune system, 3) suppression of 11 Proteobacterial colonization or infection by taking up a ecological niche in the microbiota, and 4) direct 12 killing of Proteobacteria. Interestingly, a recent study in mice reported that the acquisition of a 13
Bacteroidetes-rich lung microbiota during early life was associated with the establishment of tolerance in 14 the lung and suppression of allergic inflammation, whereas Proteobacterial-rich lungs of neonatal mice 15 showed exaggerated responses to allergen (51). Additionally, we have previously reported that Prevotella 16 spp. modulates the in vitro inflammatory response of human dendritic cells to Haemophilus influenzae 17 suggesting that members of the commensal lung microbiota may directly limit the immune response to 18 specific pathogens (41). Additional studies are needed to establish if Prevotella spp. exhibit causal disease-19 protective effects. 20
We found that the three Proteobacteria associated with COPD and asthma potently mediated airway 21 neutrophilia, inflammatory chemokine/cytokine production and tissue pathology in mice. This is in line with 22 previous studies reporting, that certain Proteobacteria can induce COPD-like inflammatory features and 23 promote COPD disease in murine models (28-30). The results from murine studies support the notion of 24 pathogenic Proteobacteria as potential co-drivers of COPD disease (21-24). We speculate that it is the 25 specific immune active hexa-acylated structure of LPS in these bacterial strains that gives the bacteria its 1 disease-promoting activity. Indeed, inhalation of LPS in humans mediates production of IL-1β, IL-6 and 2 TNFα, neutrophil recruitment and decreased lung function (FEV1) (52, 53). Based on these findings it could 3 be proposed to examine the applicability of inhaled TLR4 antagonists as an option for treatment of chronic 4 inflammatory airway disease with involvement of pathogenic Proteobacteria. 5 
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